Medable: COVID-19 fueling decentralized trial adoption
The company credits its 400% year-over-year growth to rapid acceleration in adoption of virtual clinical trial technology, due in part to the vlrus.
The company credits its 400% year-over-year growth to rapid acceleration in adoption of virtual clinical trial technology, due in part to the vlrus.
The company is delving into clinical research partnerships geared toward saving the lives of soldiers, eventually translating findings to civilian care.
The clinical research service provider is opening a new CRO site in the UK to meet growing demand from biotech industry clients.